We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Maravai LifeSciences Holdings Inc | NASDAQ:MRVI | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.04 | 0.45% | 9.01 | 8.40 | 9.07 | 9.08 | 8.855 | 8.99 | 2,300,344 | 21:37:44 |
From May 2021 to May 2024
On November 17, 2021, Kevin Herde, Chief Financial Officer, will participate in a fireside chat at the Stifel Healthcare Conference at 10:20 a.m. PT.
On November 30, 2021, Kevin Herde, Chief Financial Officer, will present at the Nasdaq Investor Conference at 7:00 a.m. PT.
A live webcast of the presentations will be available to all interested parties on the Maravai Lifesciences investor relations website at http://investors.maravai.com. An archived version of the webcast will be available shortly after the completion of each event on the Maravai investor relations website.
About Maravai Maravai is a leading life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines and to support research on human diseases. Maravai’s companies are leaders in providing products and services in the fields of nucleic acid synthesis and biologic safety testing to many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies. For more information about Maravai LifeSciences, visit www.maravai.com.
Contact Information: Media Contact: Sara Michelmore MacDougall Advisors +1 781-235-3060 maravai@macbiocom.com Investor Contact: Deb Hart Maravai LifeSciences + 1 858-988-5917 ir@maravai.com
1 Year Maravai LifeSciences Chart |
1 Month Maravai LifeSciences Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
